344 related articles for article (PubMed ID: 15651898)
21. Current developments in activity-based protein profiling.
Willems LI; Overkleeft HS; van Kasteren SI
Bioconjug Chem; 2014 Jul; 25(7):1181-91. PubMed ID: 24946272
[TBL] [Abstract][Full Text] [Related]
22. Aptamer-based multiplexed proteomic technology for biomarker discovery.
Gold L; Ayers D; Bertino J; Bock C; Bock A; Brody EN; Carter J; Dalby AB; Eaton BE; Fitzwater T; Flather D; Forbes A; Foreman T; Fowler C; Gawande B; Goss M; Gunn M; Gupta S; Halladay D; Heil J; Heilig J; Hicke B; Husar G; Janjic N; Jarvis T; Jennings S; Katilius E; Keeney TR; Kim N; Koch TH; Kraemer S; Kroiss L; Le N; Levine D; Lindsey W; Lollo B; Mayfield W; Mehan M; Mehler R; Nelson SK; Nelson M; Nieuwlandt D; Nikrad M; Ochsner U; Ostroff RM; Otis M; Parker T; Pietrasiewicz S; Resnicow DI; Rohloff J; Sanders G; Sattin S; Schneider D; Singer B; Stanton M; Sterkel A; Stewart A; Stratford S; Vaught JD; Vrkljan M; Walker JJ; Watrobka M; Waugh S; Weiss A; Wilcox SK; Wolfson A; Wolk SK; Zhang C; Zichi D
PLoS One; 2010 Dec; 5(12):e15004. PubMed ID: 21165148
[TBL] [Abstract][Full Text] [Related]
23. The pivotal role of reactivity in the design of novel biotinylation reagents for the chemical-proteomics-based identification of vascular accessible biomarkers.
Hanke SA; Kerner A; Nadler WM; Trumpp A; Zhang Y; Rösli CP
J Proteomics; 2016 Jun; 141():57-66. PubMed ID: 27113135
[TBL] [Abstract][Full Text] [Related]
24. Approaches for systematic proteome exploration.
Falk R; Ramström M; Ståhl S; Hober S
Biomol Eng; 2007 Jun; 24(2):155-68. PubMed ID: 17376740
[TBL] [Abstract][Full Text] [Related]
25. The proteomics big challenge for biomarkers and new drug-targets discovery.
Savino R; Paduano S; Preianò M; Terracciano R
Int J Mol Sci; 2012 Oct; 13(11):13926-48. PubMed ID: 23203042
[TBL] [Abstract][Full Text] [Related]
26. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
Núñez Galindo A; Macron C; Cominetti O; Dayon L
Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
[TBL] [Abstract][Full Text] [Related]
27. Analytical platforms for activity-based protein profiling--exploiting the versatility of chemistry for functional proteomics.
Sieber SA; Cravatt BF
Chem Commun (Camb); 2006 Jun; (22):2311-9. PubMed ID: 16733565
[TBL] [Abstract][Full Text] [Related]
28. Next generation chemical proteomic tools for rapid enzyme profiling.
Uttamchandani M; Lu CH; Yao SQ
Acc Chem Res; 2009 Aug; 42(8):1183-92. PubMed ID: 19435360
[TBL] [Abstract][Full Text] [Related]
29. Proteomics-based anticancer drug discovery and development.
Jain KK
Technol Cancer Res Treat; 2002 Aug; 1(4):231-6. PubMed ID: 12625781
[TBL] [Abstract][Full Text] [Related]
30. Drug Screening Platforms and RPPA.
Dawson JC; Warchal SJ; Carragher NO
Adv Exp Med Biol; 2019; 1188():203-226. PubMed ID: 31820390
[TBL] [Abstract][Full Text] [Related]
31. Activity-Based Protein Profiling for the Study of Parasite Biology.
Benns HJ; Tate EW; Child MA
Curr Top Microbiol Immunol; 2019; 420():155-174. PubMed ID: 30105424
[TBL] [Abstract][Full Text] [Related]
32. [Chemical proteomics and discovery of drug targets].
Yang HQ; Li XJ
Yao Xue Xue Bao; 2011 Aug; 46(8):877-82. PubMed ID: 22007509
[TBL] [Abstract][Full Text] [Related]
33. Chemical proteomics: terra incognita for novel drug target profiling.
Huang F; Zhang B; Zhou S; Zhao X; Bian C; Wei Y
Chin J Cancer; 2012 Nov; 31(11):507-18. PubMed ID: 22640626
[TBL] [Abstract][Full Text] [Related]
34. Proteomic profiling of human plasma for cancer biomarker discovery.
Huang Z; Ma L; Huang C; Li Q; Nice EC
Proteomics; 2017 Mar; 17(6):. PubMed ID: 27550791
[TBL] [Abstract][Full Text] [Related]
35. Reimagining Druggability Using Chemoproteomic Platforms.
Spradlin JN; Zhang E; Nomura DK
Acc Chem Res; 2021 Apr; 54(7):1801-1813. PubMed ID: 33733731
[TBL] [Abstract][Full Text] [Related]
36. Profiling the specific reactivity of the proteome with non-directed activity-based probes.
Adam GC; Cravatt BF; Sorensen EJ
Chem Biol; 2001 Jan; 8(1):81-95. PubMed ID: 11182321
[TBL] [Abstract][Full Text] [Related]
37. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
[TBL] [Abstract][Full Text] [Related]
38. Proteomics: recent applications and new technologies.
Elrick MM; Walgren JL; Mitchell MD; Thompson DC
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):432-41. PubMed ID: 16635100
[TBL] [Abstract][Full Text] [Related]
39. Proteomics meets microbiology: technical advances in the global mapping of protein expression and function.
Phillips CI; Bogyo M
Cell Microbiol; 2005 Aug; 7(8):1061-76. PubMed ID: 16008574
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
